Effects of Shenlian Extracts on Rat Peritoneal Mast Cells Activation
|更新时间:2024-01-04
|
Effects of Shenlian Extracts on Rat Peritoneal Mast Cells Activation
Chinese Journal of Experimental Traditional Medical FormulaeVol. 19, Issue 6, Pages: 196-199(2013)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2013
稿件说明:
移动端阅览
RUAN Cong-xiao, LI Yu-jie, Yang Qing, et al. Effects of Shenlian Extracts on Rat Peritoneal Mast Cells Activation[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 196-199.
DOI:
RUAN Cong-xiao, LI Yu-jie, Yang Qing, et al. Effects of Shenlian Extracts on Rat Peritoneal Mast Cells Activation[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 196-199.DOI:
Effects of Shenlian Extracts on Rat Peritoneal Mast Cells Activation
Objective: To investigate the effects of Shenlian (SL) extracts on mast cells activation. Method: Rat peritoneal mast cells (RPMC) were collected and seeded on 96-well plates. Compound 48/80 was added into the cultural supernatants after the cells were pretreated with SL extracts for 2 h. Then we collected the supernatants and detected Histamine
5-hydroxytryptamine and tryptase content with ELISA kits. Result: The results show Compound 48/80 increased histamine release from 32.36% to 61.71% (P<0.01). SL extracts(100
50
25
12.5 mg·L-1) reduced RPMC histamine release to 16.24%
26.25%
27.81%
31.50%(P<0.01). Compound 48/80 increased tryptase release from 13.19% to 21.72% (P<0.01)
SL extracts(100
50
25
12.5 mg·L-1) reduced RPMC tryptase release to 8.60%
15.78%
8.80%
12.15% (100
25
12.5 mg·L-1
P<0.01
50 mg·L-1
P<0.05). Compound 48/80 had no obvious effect on RPMC 5-HT release. But 100
50
25 mg·L-1 of SL extracts can increase 5-HT release (100
50 mg·L-1
P<0.01; 25 mg·L-1
P<0.05). Conclusion: We concluded SL extracts can stabilize mast cells.
Exploration of Zhuyuwan in Treatment of Atherosclerosis from Perspective of Lipid Transport Disorder
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Effect of Co-treatment Method of Stagnation of Phlegm and Blood Stasis (Danlou Tablet) on Vascular Endothelial Function in Patients with Atherosclerosis
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Related Author
SONG Wei
ZHANG Zhongyi
QIU Hairong
ZHAO Mei
ZHOU Zubing
SHEN Tao
ZHANG Yong
LIANG Yuqin
Related Institution
Chengdu University of Traditional Chinese Medicine(TCM)
Hospital of Chengdu University of TCM
Hubei Minzu University
Institute of TCM, Sichuan Academy of Chinese Medicine Sciences
Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine